Clinical trial · Observational
HIV Self-Testing AND Uptake and Retention of PrEP Among Older Adolescent MSM and TGW
Study to Determine the Effect of HIV Self-testing on the Uptake of and Retention in Pre-exposure Prophylaxis Service Among Older Adolescent Men Who Have Sex With Men and Transgender Women
NCT03745495CI-TRIAL-00083000completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This will be a prospective study that will enroll up to 600 older adolescent MSM and TGW from community-based clinics in Bangkok, Chonburi, Chiang Mai, and Songkhla.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Men or Transgender Women Who Have Sex With Men | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Group 1
- description
- 300 To determine the effect of HIVST on PrEP uptake among older adolescent MSM and TGW
- label
- Group 2
- description
- 300 To determine the effect of HIVST on retention of older adolescent MSM and TGW in HIV service
Primary outcomes (2)
- measure
- Proportion of participants starting PrEP among those who use and do not use HIVST
- timeFrame
- 3 years
- measure
- Proportion of participants taking PrEP retaining in care among those who use and do not use HIVST
- timeFrame
- 3 years
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 15 Years
- Maximum age
- 19 Years
Show eligibility criteria text
Inclusion Criteria: 1. Thai nationality 2. Age 15-19 years old 3. Men or transgender women who have sex with men 4. HIV-negative at the time of screening 5. Have at least one of the following risks for HIV acquisition in the past 6 months: 1. Any unprotected receptive anal sex with a male partner 2. More than 5 male partners, regardless of condom use and serostatus 3. Has had a bacterial sexually transmitted infection (STI) 4. Any injected drug use 6. Calculated creatinine clearance (CrCl) ≥ 75 mL/min, as estimated by the Cockcroft- Gault equation 7. Alanine aminotransferase (ALT) ≤ 2.5 x ULN 8. Have signed the informed consent form Exclusion Criteria: 1. HIV-positive 2. Hepatitis B infection as indicated by positive hepatitis B surface antigen (HBsAg) test at time of screening 3. Known allergy/sensitivity to tenofovir or emtricitabine
References
Publications (0)
Data not yet available
No reference posted for this study.